Intraperitoneal vs systemic cisplatin in combination with systemic epidoxorubicin+ clophosphamide in advanced ovarian cancer patients with minimal residual disease after prior surgery: Update of a randomized study

Authors :: Romanini, A
Tanganelli, L
Gadducci, Angiolo
Brunetti, I
Bruzzone, M
Mammoliti, S
Carnino, F
Conte, Pf
Publication Year :: 1997

Tools